CTV National News: Experimental diabetes treatments hits major milestone
A Canadian woman is praising an experimental treatment for diabetes. Avis Favaro with more on her experience.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBC
18 minutes ago
- CBC
Bat infected with rabies found in Mississauga, Peel Public Health says
A bat has tested positive for rabies in Mississauga and public health officials are reminding residents to avoid touching wild or unknown animals. Infectious diseases specialist Dr. Isaac Bogoch breaks down what people should know about the virus.
Globe and Mail
an hour ago
- Globe and Mail
Women's Health Collective Canada and Shoppers Foundation for Women's Health™ Deepen Partnership with $1 Million Commitment to Health Research and Care
TORONTO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Shoppers Foundation for Women's Health™ is building on its commitment to advancing health equity for women with a $1 million investment in health research and care, over the next two years, through Women's Health Collective Canada (WHCC), the largest non-government funder of women's health research in Canada. This investment will support research on, and improved care for menopause, a long-overlooked area of women's health. This latest investment builds on three years of sustained partnership, with total contributions to WHCC of over $3 million. As WHCC's Founding Partner, Shoppers Foundation for Women's Health™ has played a leading role in bringing attention to the gaps in women's health and helping to close them through bold, strategic investment. Their early and ongoing support helped catalyze momentum that's now being recognized and echoed by other leading companies. 'This is more than generosity, it's leadership,' said Amy Flood, Executive Director, WHCC. 'Shoppers has believed in our work from the beginning, and they've helped shape a movement. With this renewed commitment, we're taking meaningful steps toward a new standard of care for menopause in Canada — something long overdue. Together, we're reaching more women, funding more research, and making the case for system-wide change.' "We are proud to continue our partnership with WHCC to help close the women's health gap in Canada," says Paulette Minard, Director, Community Investment, Shoppers Foundation for Women's Health. "This investment reflects our ongoing commitment to supporting women in our communities at every life stage—through better research, better care, and better outcomes.' This investment will support the development of an enhanced, evidence-based standard of care for menopause in Canada. Through the WHCC national network, funding will help accelerate local and regional initiatives — ensuring that women, no matter where they live, benefit from improved access to high-quality menopause care. About Women's Health Collective Canada (WHCC) Women's Health Collective Canada (WHCC) is a strategic alliance of Canada's leading women's health and hospital foundations working together to advance equity in women's health research and care. WHCC brings together resources, fundraising, education and advocacy, working alongside partners who share the vision to improve outcomes and drive lasting change in women's health. WHCC consists of the BC Women's Health Foundation, Alberta Women's Health Foundation, Women's College Hospital Foundation, the McGill University Health Centre Foundation, and the IWK Foundation. To learn more about WHCC, its members and their work, or to donate, please visit Shoppers Foundation for Women's Health™ – the charitable arm of Shoppers Drug Mart ® – is committed to helping Canadian women lead healthier lives, by making care more equitable and accessible. The Foundation will invest $50M by 2026 to address some of the most pressing health inequities facing women, including lack of representation in health research, barriers to accessing mental healthcare, and the urgent consequences women disproportionately face due to poverty and domestic violence. Learn more at
Globe and Mail
an hour ago
- Globe and Mail
PL Developments Builds a Smarter, Healthier Supply Chain with Kinaxis
Kinaxis ® (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced that PL Developments (PLD), a leading manufacturer and distributer of over-the-counter pharmaceuticals and healthcare products, has selected the Kinaxis Maestro™ platform to meet growing demand from consumers and major U.S. retailer partners. By replacing manual tools and spreadsheets with AI-powered orchestration and predictive planning, PLD will accelerate the delivery of essential healthcare products with greater agility, accuracy and efficiency. Specializing in end-to-end solutions from product development to distribution, PLD supplies some of the largest retailers in the U.S. including Walmart, Walgreens, CVS, Costco, Sam's Club and Target with health and wellness products in categories including analgesics, cough/cold, allergy and digestive. Due to market expansion and rapidly increasing consumer demand for accessible and affordable healthcare products, PLD needed to deliver to its retail partners with greater speed, accuracy and responsiveness. With manual planning tools and siloed decision-making, PLD was challenged by limited visibility across its operations leading to delayed order confirmations and high inventory levels. To maintain its position as a trusted industry leader, PLD needed a next-generation supply chain platform to meet evolving customer expectations while continuing to deliver on the promise of quality at every step. After rigorous evaluation, Maestro stood out for its unmatched ability to unify data and provide real-time insights, enabling predictive planning to anticipate demand. Maestro allows PLD to optimize inventory, respond faster to market shifts and scale execution across every function of the business with fewer resources and greater supply chain visibility. 'Consumers expect fast access to trusted health and wellness products, and our retail partners need the inventory to match shifting demand,' s aid Thomas Crowe, chief supply chain officer at PL Developments. 'With Maestro, we can anticipate this demand, simulate scenarios, plan for market shifts and make confident, data-driven decisions in minutes. It's a game changer that empowers our team to deliver the innovation and products consumers rely on every single day and Kinaxis is now a key part of that innovation.' 'PLD is a prime example of a forward-thinking manufacturer embracing the speed and intelligence today's healthcare supply chains demand,' said Mark Morgan, president of global commercial operations at Kinaxis. 'With Maestro, they're not just replacing spreadsheets, they're unlocking real-time visibility, rapid execution and scalable decision making. We're proud to support PLD as they deliver the trusted healthcare products consumers rely on, faster and more efficiently than ever.' To learn more about Kinaxis and its supply chain management solutions, please visit About Kinaxis Kinaxis is a global leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them, in service of humanity. Our powerful, AI-infused supply chain orchestration platform, Maestro™ combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain — from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today's volatility and disruption. For more news and information, please visit or follow us on LinkedIn.
